Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
Go back to Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®| Pfizer Inc. (NYSE: PFE) | Delayed: 30.57 +0.62 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.95 | 52 Week High | $37.39 | |||
| Open | $30.51 | 52 Week Low | $28.25 | |||
| Day High | $30.65 | P/E | 18.53 | |||
| Day Low | $30.14 | EPS | $1.65 | |||
| Volume | 15,948,639 | |||||



